People's Hospital of Xinjiang Uygur Autonomous Region

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study	Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous lupus erythematosus, skin disorder	Recruiting	Phase 2	2026-06-08		NCT07440537
Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease	autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated disease	Active, not recruiting	Phase 2 / Phase 3	2026-01-08		NCT06452537

Clinical trials